Completed Access to Information Requests

About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Current Search

Report Type

Organization

Disposition

Year

Month

Found 4298 record(s)

Req # A-2019-00083

Provide the minutes of the Regulatory Framework Steering Committee for 2019.

Organization: Canadian Nuclear Safety Commission

32 page(s)
January 2020

Req # A-2019-00088

Please provide all CNSC internal correspondence and also CNSC correspondence with AECL, CNL, IAEA, Vienna Permanent Mission and any Canadian or foreign government department or private company (emails, reports, phone transcripts, presentations) containing information since January 2016, regarding: 1. The International Independent Peer Review (IIPR) of the NSDF at Chalk River; and 2. The proposed IAEA ARTEMIS review mission for the NSDF at Chalk River. The following specific information is requested: A) The proposed scope of the ARTEMIS review of CNL’s NSDF safety case, envisaged by the last bullet of slide 27 of the CNSC presentation of May 17, 2018: Canadian Update to the International Nuclear Regulators Association, Gyeongju, Republic of Korea, e-Doc 5514465. B) Prior correspondence, relating to page 9 of the August 13, 2019, e-mail of ATIP-2019-00054AI reference to the 2017 CNSC initiative for an independent third party review of the NSDF by the IAEA. C) All correspondence prior to and subsequent to p. 11 of the email of November 2, 2017, ATIP-2019-00054AI, relating to the CNSC payment of and discussions with the IAEA for the ARTEMIS NSDF peer review, including information on the changes made leading to the withdrawal of the ARTEMIS review proposal. Information already provided in ATIP-2019-00054AI is not required. The CNSC presentation of May 17, 2018, e-Doc 5514465 is also not required. Follow up information from ATI A-2019-00054AI.

Organization: Canadian Nuclear Safety Commission

4 page(s)
January 2020

Req # A-2014-000300

All records related to the use of antibiotics in livestock and to antimicrobial resistance from January 1, 2012 to March 20, 2015.

Organization: Health Canada

138 page(s)
January 2020

Req # A-2015-000481

All copies of Domestic Adverse Reaction Reports where Tofacitinib/Xeljanz (Drug Identification Number (DIN): 02423898) is identified as the primary suspect drug from January 1. 2005-December 31, 2015.

Organization: Health Canada

737 page(s)
January 2020

Req # A-2015-000494

All records related to a meeting of the Working Group on Articles 9 and 10 of the World Health Organization Framework Convention on Tobacco Control held in Turkey in February 2016, including Mr. Denis Choiniere and Mr. Matthew Cook.

Organization: Health Canada

134 page(s)
January 2020

Req # A-2016-000278

All records relating to altering the provisional tolerable weekly intake (pTWI) for lead of 25 µg/kg SW/week in relation to lead in food from January 1, 2010 to May 30, 2016.

Organization: Health Canada

363 page(s)
January 2020

Req # A-2016-000700

All records pertaining to all travel by the Minister, Minister of State, Parliamentary Secretary and exempt staff from February 6, 2006 to August 13, 2007, and from July 15, 2013 to November 3, 2015.

Organization: Health Canada

1638 page(s)
January 2020

Req # A-2019-001549

Adverse Reaction Report (AER) for Acarizax. Report number: E2B_02679398.

Organization: Health Canada

7 page(s)
January 2020

Req # A-2016-000882

January 1, 2004 to October 11, 2016. All records regarding requests for information issued, directions to Stop Sale issued, suspensions or Cancellations issued, enforcement actions taken related to Natural Health Products for non-compliance with the Food and Drugs Act or the Natural Health Product Regulations.

Organization: Health Canada

133 page(s)
January 2020

Req # A-2016-001523

All Task Authorizations and Statements of Work issued under the following contract numbers: HT218-143802/009/ZM, HT218-143802/006/ZM, HT218-143802/012/ZM, HT218-143802/013/ZM, HT218-143802/004/ZM, HT218-143802/002/ZM, HT218-143802/015/ZM, HT218-143802/014/ZM, HT218-143802/010/ZM, HT218-143802/019/ZM, HT218-143802/018/ZM, HT218-143802/017/ZM, HT218-143802/011/ZM, HT218-143802/001/ZM, HT218-143802/005/ZM, HT218-143802/003/ZM.

Organization: Health Canada

540 page(s)
January 2020
Date modified: